biotech · Relapsed/Refractory Multiple Myeloma · Respiratory Distress Syndrome, Adult · INKT
MiNK Therapeutics
MiNK Therapeutics clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
NEW YORK, NY, SE HQ
2012 Founded
9 Employees
Public company Type
INKT · NYSE Ticker
Company details
- Status
- Public
- HQ
- NEW YORK, NY, SE
- Founded
- 2012
- Employees
- 9
- Programs
- 3
- Drugs
- 1
- Patents
- 6
MiNK Therapeutics projects
3 ClinicalTrials.gov programs sponsored by MiNK Therapeutics.
MiNK Therapeutics has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does MiNK Therapeutics have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.